About this Journal Submit a Manuscript Table of Contents
International Journal of Endocrinology
Volume 2013 (2013), Article ID 858206, 5 pages
http://dx.doi.org/10.1155/2013/858206
Research Article

Determinants of Microbial Load in Infected Diabetic Foot Ulcers: A Pilot Study

1Outpatient Clinic of the Diabetic Foot, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Dragana, 68100 Alexandroupolis, Greece
2Microbiology Laboratory, Democritus University of Thrace, University Hospital of Alexandroupolis, Dragana, 68100 Alexandroupolis, Greece

Received 29 May 2013; Accepted 10 June 2013

Academic Editor: Ilias Migdalis

Copyright © 2013 M. Demetriou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. M. Boulton, “The diabetic foot: grand overview, epidemiology and pathogenesis,” Diabetes/Metabolism Research and Reviews, vol. 24, supplement 1, pp. S3–S6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Papanas, E. Maltezos, and M. Edmonds, “Salvation of the diabetic foot: still a quest for the holy grail?” Vasa, vol. 40, no. 4, pp. 267–269, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Papanas and E. Maltezos, “The diabetic foot: a global threat and a huge challenge for Greece,” Hippokratia, vol. 13, no. 4, pp. 199–204, 2009.
  4. N. Papanas and M. K. Lazarides, “Diabetic foot amputations in Greece: where do we go from here?” International Journal of Lower Extremity Wounds, vol. 10, no. 1, pp. 4–5, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Skoutas, N. Papanas, G. S. Georgiadis et al., “Risk factors for ipsilateral reamputation in patients with diabetic foot lesions,” International Journal of Lower Extremity Wounds, vol. 8, no. 2, pp. 69–74, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Tentolouris, S. Al-Sabbagh, M. G. Walker, A. J. M. Boulton, and E. B. Jude, “Mortality in diabetic and nondiabetic patients after amputations performed from 1990 to 1995: a 5-year follow-up study,” Diabetes Care, vol. 27, no. 7, pp. 1598–1604, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Edmonds, “Modern treatment of infection and ischaemia to reduce major amputation in the diabetic foot,” Current Pharmaceutical Design. In press.
  8. E. Georgakarakos, N. Papanas, E. Papadaki, G. S. Georgiadis, E. Maltezos, and M. K. Lazarides, “Endovascular treatment of critical ischemia in the diabetic foot: new thresholds, new anatomies,” Angiology. In press.
  9. K. I. Paraskevas, V. G. Athyros, D. D. Briana, A. I. Kakafika, A. Karagiannis, and D. P. Mikhailidis, “Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures,” Current Drug Targets, vol. 8, no. 8, pp. 942–951, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Papanas and E. Maltezos, “α-lipoic acid, diabetic neuropathy, and Nathan's prophecy,” Angiology, vol. 63, no. 2, pp. 81–83, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Papanas and E. Maltezos, “Cilostazol in diabetic neuropathy: premature farewell or new beginning?” Angiology, vol. 62, no. 8, pp. 605–608, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. B. A. Lipsky, E. J. G. Peters, A. R. Berendt et al., “Specific guidelines for the treatment of diabetic foot infections 2011,” Diabetes/Metabolism Research and Reviews, vol. 28, no. 1, pp. 234–235, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. B. A. Lipsky, E. J. G. Peters, E. Senneville et al., “Expert opinion on the management of infections in the diabetic foot,” Diabetes/Metabolism Research and Reviews, vol. 28, supplement 1, pp. 163–178, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Papanas and E. Maltezos, “Growth factors in the treatment of diabetic foot ulcers: new technologies, any promises?” International Journal of Lower Extremity Wounds, vol. 6, no. 1, pp. 37–53, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. E. K. Tiaka, N. Papanas, A. C. Manolakis, and G. S. Georgiadis, “Epidermal growth factor in the treatment of diabetic foot ulcers: an update,” Perspectives in Vascular Surgery and Endovascular Therapy, vol. 24, no. 1, pp. 37–44, 2012.
  16. E. K. Tiaka, N. Papanas, A. C. Manolakis, and E. Maltezos, “The role of hyperbaric oxygen in the treatment of diabetic foot ulcers,” Angiology, vol. 63, no. 4, pp. 302–314, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Antonoglou, N. Papanas, and E. Maltezos, “Lipid-lowering therapy in the diabetic foot: seeing the whole iceberg and not just the tip,” Current Vascular Pharmacology. In press.
  18. N. Papanas and E. Maltezos, “Polyherbal formulation as a therapeutic option to improve wound healing in the diabetic foot,” Indian Journal of Medical Research, vol. 134, no. 8, pp. 146–147, 2011. View at Scopus
  19. J. Aragón-Sánchez, J. L. Lázaro-Martínez, J. Pulido-Duque, and M. Maynar, “From the diabetic foot ulcer and beyond: how do foot infections spread in patients with diabetes?” Diabetic Foot and Ankle, vol. 3, 2012. View at Publisher · View at Google Scholar
  20. J. Aragón-Sánchez, J. L. Lázaro-Martínez, C. Hernández-Herrero et al., “Surgical treatment of limb- and life-threatening infections in the feet of patients with diabetes and at least one palpable pedal pulse: successes and lessons learnt,” International Journal of Lower Extremity Wounds, vol. 10, no. 4, pp. 207–213, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Tentolouris, G. Petrikkos, N. Vallianou et al., “Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers,” Clinical Microbiology and Infection, vol. 12, no. 2, pp. 186–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Eleftheriadou, N. Tentolouris, V. Argiana, E. Jude, and A. J. Boulton, “Methicillin-resistant staphylococcus aureus in diabetic foot infections,” Drugs, vol. 70, no. 14, pp. 1785–1797, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Aragón-Sánchez, B. A. Lipsky, and J. L. Lázaro-Martínez, “Gram-negative diabetic foot osteomyelitis: risk factors and clinical presentation,” The International Journal of Lower Extremity Wounds, vol. 12, no. 1, pp. 63–68, 2013.
  24. A. Cecilia-Matilla, J. L. Lázaro-Martínez, J. Aragón-Sánchez, et al., “Histopathologic characteristics of bone infection complicating foot ulcers in diabetic patients,” Journal of the American Podiatric Medical Association, vol. 103, no. 1, pp. 24–31, 2013.
  25. L. J. Wheat, S. D. Allen, and M. Henry, “Diabetic foot infections. Bacteriologic analysis,” Archives of Internal Medicine, vol. 146, no. 10, pp. 1935–1940, 1986. View at Scopus
  26. C. S. Sharp, A. N. Bessman, F. W. Wagner Jr., and D. Garland, “Microbiology of deep tissue in diabetic gangrene,” Diabetes Care, vol. 1, no. 5, pp. 289–292, 1978. View at Scopus
  27. F. L. Sapico, H. N. Canawati, and J. L. Witte, “Quantitative aerobic and anaerobic bacteriology of infected diabetic feet,” Journal of Clinical Microbiology, vol. 12, no. 3, pp. 413–420, 1980. View at Scopus
  28. M. Demetriou, N. Papanas, M. Panopoulou, K. Papatheodorou, A. Bounovas, and E. Maltezos, “Tissue and swab culture in diabetic foot infections: neuropathic versus neuroschaemic ulcers,” The International Journal of Lower Extremity Wounds, vol. 12, no. 2, pp. 87–93, 2013. View at Publisher · View at Google Scholar
  29. L. Prompers, M. Huijberts, J. Apelqvist et al., “High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study,” Diabetologia, vol. 50, no. 1, pp. 18–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. M. E. Edmonds, A. V. M. Foster, and L. J. Sanders, “Stage 3: the ulcerated foot,” in A Practical Manual of Diabetic Footcare, M. E. Edmonds, A. V. M. Foster, and L. J. Sanders, Eds., pp. 62–101, Blackwell, Oxford, UK, 2004.
  31. N. C. Schaper, “Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies,” Diabetes/Metabolism Research and Reviews, vol. 20, supplement 1, pp. S90–S95, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. L. A. Lavery, D. G. Armstrong, and L. B. Harkless, “Classification of diabetic foot wounds,” Journal of Foot and Ankle Surgery, vol. 35, no. 6, pp. 528–531, 1996. View at Scopus
  33. I. Byren, E. J. G. Peters, C. Hoey, A. Berendt, and B. A. Lipsky, “Pharmacotherapy of diabetic foot osteomyelitis,” Expert Opinion on Pharmacotherapy, vol. 10, no. 18, pp. 3033–3047, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. J. Young, A. J. M. Boulton, A. F. Macleod, D. R. R. Williams, and P. H. Sonksen, “A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population,” Diabetologia, vol. 36, no. 2, pp. 150–154, 1993. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Papanas, G. Symeonidis, G. Mavridis et al., “Ankle-brachial index: a surrogate marker of microvascular complications in type 2 diabetes mellitus?” International Angiology, vol. 26, no. 3, pp. 253–257, 2007. View at Scopus
  36. K. I. Paraskevas, I. Kotsikoris, S. A. Koupidis, A. D. Giannoukas, and D. P. Mikhailidis, “Editorial: Ankle-brachial index: a marker of both peripheral arterial disease and systemic atherosclerosis as well as a predictor of vascular events,” Angiology, vol. 61, no. 6, pp. 521–523, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. K. York, “Aerobic Bacteriology. Quantitative cultures of wound tissues,” in Clinical Microbiology Procedures Handbook, H. D. Isenberg, Ed., section 3.13.2, ASM Press, Washington, DC, USA, 2nd edition, 2004.
  38. L. Rabjohn, K. Roberts, M. Troiano, and H. Schoenhaus, “Diagnostic and prognostic value of erythrocyte sedimentation rate in contiguous osteomyelitis of the foot and ankle,” Journal of Foot and Ankle Surgery, vol. 46, no. 4, pp. 230–237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. M. B. Pepys and G. M. Hirschfield, “C-reactive protein: a critical update,” Journal of Clinical Investigation, vol. 111, no. 12, pp. 1805–1812, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Dinh, G. Snyder, and A. Veves, “Current techniques to detect foot infection in the diabetic patient,” International Journal of Lower Extremity Wounds, vol. 9, no. 1, pp. 24–30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Michail, E. Jude, C. Liaskos, et al., “The performance of serum inflammatory markers for the diagnosis and follow-up of patients with osteomyelitis,” The International Journal of Lower Extremity Wounds, vol. 12, no. 2, pp. 94–99, 2013.
  42. E. Gouveri and N. Papanas, “Charcot osteoarthropathy in diabetes: a brief review with an emphasis on clinical practice,” World Journal of Diabetes, vol. 2, no. 5, pp. 59–65, 2011.
  43. M. E. Edmonds, A. V. M. Foster, and L. J. Sanders, “Stage 4: the infected foot,” in A Practical Manual of Diabetic Footcare, M. E. Edmonds, A. V. M. Foster, and L. J. Sanders, Eds., pp. 102–140, Blackwell, Oxford, UK, 2004.
  44. J. Aragón-Sánchez, J. L. Lázaro-Martínez, C. Hernández-Herrero et al., “Surgical treatment of limb- and life-threatening infections in the feet of patients with diabetes and at least one palpable pedal pulse: successes and lessons learnt,” International Journal of Lower Extremity Wounds, vol. 10, no. 4, pp. 207–213, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. C. A. Abbott, A. L. Carrington, H. Ashe et al., “The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort,” Diabetic Medicine, vol. 19, no. 5, pp. 377–384, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Papanas, A. I. Vinik, and D. Ziegler, “Neuropathy in prediabetes: does the clock start ticking early?” Nature Reviews Endocrinology, vol. 7, no. 11, pp. 682–690, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Papanas, A. J. Boulton, R. A. Malik, et al., “A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy,” Diabetic Medicine, vol. 30, no. 5, pp. 525–534, 2013.